TADAFLO 10

What is TADAFLO 10?

TADAFLO 10 is a medicinal product by the Indian pharmaceutical company Cipla, belonging to the group of selective phosphodiesterase type 5 (PDE-5) inhibitors. The main active substance of the drug is tadalafil at a dosage of 10 mg, which provides a pronounced therapeutic effect in erectile dysfunction of various origins. Thanks to Cipla's high manufacturing standards, TADAFLO 10 complies with international quality, bioequivalence, and safety requirements, as confirmed by numerous clinical studies. The drug is released in the form of film-coated tablets, convenient for oral administration. Tadalafil in TADAFLO 10 differs from other members of the group by a longer period of action, which allows the patient not to tie the intake of the drug to a specific moment of intimacy.

TADAFLO 10 belongs to the category of drugs for the treatment of erectile dysfunction; however, its pharmacological profile is significantly broader than symptomatic correction. Tadalafil affects the phosphodiesterase-5 enzyme, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the cavernous bodies of the penis. Inhibition of this enzyme leads to the accumulation of cGMP, relaxation of vascular smooth muscle, and enhanced blood filling of the cavernous bodies during sexual arousal. It is important to understand that TADAFLO 10 does not cause an erection without natural sexual stimulation, but only restores the physiological response to it. Such a mechanism of action is considered the most physiological among the available means of correcting erectile dysfunction.

The manufacturer Cipla is one of the world's largest pharmaceutical companies specializing in the production of high-quality generics and original drugs. Cipla products undergo multi-stage quality control at all stages of production, from substance synthesis to packaging of the finished dosage form. TADAFLO 10 is manufactured in modern facilities certified according to GMP standards, which guarantees dosage stability and predictability of the therapeutic effect. The drug is widely presented on the pharmaceutical market of Ukraine and enjoys the trust of both urologists and patients due to the optimal price-quality ratio. The availability of the 10 mg dosage allows a flexible approach to selecting therapy depending on the severity of the condition and the patient's individual sensitivity.

What is TADAFLO 10 prescribed for?

The main indication for the use of TADAFLO 10 is erectile dysfunction, which is the persistent inability to achieve and maintain an erection sufficient for satisfactory sexual intercourse. This condition can be of psychogenic, organic, or mixed origin, and tadalafil is effective in all mentioned forms. The drug helps men with vascular disorders, diabetes mellitus, arterial hypertension, atherosclerosis, and other chronic diseases that negatively affect erectile function. Clinical studies demonstrate that TADAFLO 10 improves erection quality in most patients regardless of age and duration of the problem. Importantly, the drug restores not only the mechanical component of an erection, but also the man's confidence in his own abilities, which positively affects the psycho-emotional state and couple relationships.

The second approved indication for TADAFLO 10 is benign prostatic hyperplasia (BPH) with concomitant lower urinary tract symptoms. Tadalafil relaxes the smooth muscles not only of the penile blood vessels, but also of the prostate gland, urinary bladder, and urethra, which reduces obstructive symptoms. Patients report improvements in urine flow, reduced frequency of nighttime urination, and a decreased sensation of incomplete bladder emptying. In many cases, TADAFLO 10 is prescribed to patients in whom erectile dysfunction is combined with BPH, as the drug simultaneously addresses both problems. This combined effect makes tadalafil unique among PDE-5 inhibitors and expands the physician's therapeutic options.

In certain clinical situations, TADAFLO 10 is used as part of comprehensive rehabilitation after radical prostatectomy or pelvic radiation therapy. Restoring erectile function after such interventions is an important component of returning a patient to a full life, and tadalafil demonstrates high efficacy in this group. The drug can also be used for erectile dysfunction caused by taking certain medications, particularly antidepressants and antihypertensive drugs, after consultation with a doctor. In each case, the decision to prescribe TADAFLO 10 is made by a physician based on a complete examination of the patient and an assessment of potential risks. Self-medication of erectile dysfunction is unacceptable, as it can be an early marker of serious cardiovascular diseases.

Composition and active components of TADAFLO 10

Each TADAFLO 10 tablet contains tadalafil at a dose of 10 mg as the main active substance. Tadalafil is a synthetic compound belonging to the class of selective phosphodiesterase type 5 inhibitors, designed for long-lasting and controlled action. Unlike sildenafil, the half-life of tadalafil is approximately 17.5 hours, providing a therapeutic effect for 36 hours after a single dose. This pharmacokinetic feature allows the patient to plan sexual activity without a rigid connection to the time of tablet intake. Tadalafil exhibits high selectivity for PDE-5 compared to other phosphodiesterase isoenzymes, which minimizes the risk of systemic side effects.

Excipients of TADAFLO 10 include lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hydroxypropyl cellulose, magnesium stearate, and other substances that ensure tablet stability and uniform release of the active substance. The film coating contains hypromellose, titanium dioxide, lactose, triacetin, and colorants that give the tablet its characteristic appearance and protect the active component from environmental exposure. Patients with rare hereditary lactose intolerance should consider its presence in the composition of the drug and inform their doctor about it. The excipients are selected to ensure optimal bioavailability of tadalafil and a minimal risk of allergic reactions.

The mechanism of action of tadalafil is realized through blocking the phosphodiesterase-5 enzyme, which normally degrades cGMP — a key signaling molecule responsible for relaxing vascular smooth muscles. During sexual stimulation, nitric oxide is released in the nerve endings of the cavernous bodies, activating the enzyme guanylate cyclase and increasing cGMP levels. Tadalafil prevents the premature degradation of cGMP, prolonging and enhancing the vasodilatory effect, which leads to sustained blood filling of the penis. It is important to emphasize that TADAFLO 10 does not affect libido and is not a hormonal drug; therefore, it does not disrupt the natural hormonal balance of the male body. The drug acts only in the presence of sexual arousal, making its use maximally physiological.

Dosage of TADAFLO 10

The standard recommended dose of TADAFLO 10 for adult men is 10 mg once daily prior to anticipated sexual activity. The drug can be taken regardless of food intake, as food does not affect the bioavailability of tadalafil. The maximum frequency of administration is no more than once every 24 hours, as the long half-life ensures the maintenance of therapeutic concentration in the blood for up to 36 hours. For patients planning regular sexual activity, switching to a daily intake of a lower dose of 5 mg is possible; however, such a decision is made exclusively by a doctor. The 10 mg dosage is considered optimal for most patients, as it provides a balance between efficacy and tolerability.

Dose adjustment of TADAFLO 10 may be required for patients with impaired liver or kidney function. In severe renal failure (creatinine clearance less than 30 mL/min), the maximum recommended dose is 5 mg once daily, and taking 10 mg can be dangerous due to drug accumulation in the body. For patients with severe hepatic impairment, the drug is contraindicated, as the safety of tadalafil use in this group has not been established. Elderly patients usually do not require dose adjustment; however, concomitant diseases and drug interactions should be considered. Men taking CYP3A4 inhibitors (ketoconazole, ritonavir, itraconazole) are recommended to reduce the dose of TADAFLO 10 to 5 mg with an interval of at least 72 hours.

The duration of the treatment course with TADAFLO 10 is determined individually depending on the cause of erectile dysfunction and the patient's response to therapy. With situational use, the drug is taken on demand, without the need for a continuous course of treatment. In the case of BPH or chronic erectile dysfunction, a doctor may recommend long-term daily intake at a lower dose to achieve a stable therapeutic effect. It is important not to exceed the recommended dose independently, as increasing the dose does not lead to a proportional enhancement of the effect, but increases the risk of adverse reactions. If the efficacy of TADAFLO 10 seems insufficient, it is necessary to consult a doctor to review the therapeutic strategy rather than increasing the dose on your own.

How to take TADAFLO 10 correctly?

TADAFLO 10 is taken orally, swallowing the tablet with a sufficient amount of water, regardless of meals. Unlike some other PDE-5 inhibitors, fatty foods and moderate amounts of alcohol do not significantly reduce the bioavailability of tadalafil, so the patient is not restricted in diet before taking it. The drug can be taken from 30 minutes up to 12 hours before anticipated sexual activity, as the effect develops gradually and persists for a long time. To achieve optimal results, it is recommended to take TADAFLO 10 at least 30–60 minutes before planned intimacy so that the drug has time to reach a therapeutic concentration in the blood. It is important to remember that sexual stimulation is a prerequisite for an erection to occur after taking the drug.

If a patient misses a scheduled dose of TADAFLO 10 as part of daily therapy, the tablet should be taken as soon as possible if more than 12 hours remain until the next dose. In cases where the next dose should be taken in less than 12 hours, the missed dose should be skipped, returning to the normal schedule. Doubling the dose to compensate for a missed one is strictly prohibited, as this increases the risk of developing serious side effects, including prolonged erection and arterial hypotension. Patients taking TADAFLO 10 situationally should maintain an interval of at least 24 hours between doses regardless of the circumstances. Systematic violation of the dosage regimen can lead to an unpredictable response of the body and reduced therapeutic efficacy.

Before starting TADAFLO 10, it is necessary to undergo a medical examination to exclude contraindications and assess cardiovascular risk. Patients with heart disease should discuss with a doctor the acceptability of sexual activity, as it places a strain on the cardiovascular system by itself. TADAFLO 10 is not intended for use by women, children, or adolescents under 18 years of age. The drug does not protect against sexually transmitted infections; therefore, barrier methods of contraception should be used during casual sexual contact. If any unusual symptoms occur after taking the drug, you must discontinue its use and seek medical advice.

Side effects of TADAFLO 10

The most common side effects of TADAFLO 10 are headache, dyspepsia, back pain, myalgia, facial flushing, and nasal congestion. These reactions are caused by the systemic vasodilatory effect of tadalafil and are usually mild or moderate, occurring within the first hours after administration and resolving spontaneously within 24–48 hours. Back and muscle pain is more commonly observed 12–24 hours after taking the drug and is associated with its effect on skeletal muscle; however, this symptom usually does not require discontinuation of therapy. The incidence of side effects increases with higher doses, so patients with pronounced reactions to 10 mg may be advised to reduce the dose to 5 mg. Most patients tolerate TADAFLO 10 well, and side effects decrease or completely disappear over time with continued therapy.

Uncommon adverse reactions of TADAFLO 10 include dizziness, palpitations, increased blood pressure, abdominal pain, gastroesophageal reflux, tinnitus, and visual disturbances. Rare but potentially serious complications include priapism — a prolonged erection lasting more than 4 hours, which requires immediate medical attention due to the risk of irreversible damage to penile tissue. Cases of sudden loss of vision or hearing associated with non-arteritic anterior ischemic optic neuropathy have also been rarely reported, requiring urgent medical consultation. Patients predisposed to such conditions should be warned of potential risks and the need to immediately discontinue the drug at the first sign of vision or hearing impairment. Allergic reactions to TADAFLO 10, including urticaria, angioedema, and Stevens-Johnson syndrome, occur extremely rarely but require immediate medical care.

An individual's response to TADAFLO 10 may vary depending on age, health status, comorbid conditions, and concomitant intake of other medications. Patients should closely monitor their well-being after the first doses of the drug and report any unusual symptoms to their doctor. If side effects persist for more than 48 hours or significantly impair quality of life, it is necessary to consult a physician for dose adjustment or drug replacement. In the event of chest pain, shortness of breath, fainting, or priapism, an emergency medical service must be called immediately, as these conditions can be life-threatening. Timely informing the doctor about adverse reactions helps optimize therapy and avoid serious complications.

Contraindications of TADAFLO 10

An absolute contraindication to the use of TADAFLO 10 is the concomitant use of nitrates in any dosage form, as the combination of tadalafil with nitrates can cause a critical drop in blood pressure, myocardial infarction, or stroke. Patients taking nitroglycerin, isosorbide dinitrate, isosorbide mononitrate, or other nitric oxide donors must strictly avoid TADAFLO 10. The drug is also contraindicated in patients with hypersensitivity to tadalafil or any excipient of the tablet. Men for whom sexual activity is not recommended due to severe cardiovascular diseases, such as a recent myocardial infarction (within the last 90 days), unstable angina, or severe heart failure, are not prescribed TADAFLO 10. A history of non-arteritic anterior ischemic optic neuropathy episodes is also a contraindication to the use of the drug.

Relative contraindications to TADAFLO 10 include anatomical deformation of the penis, such as Peyronie's disease, angulation, or cavernosal fibrosis, as well as conditions that increase the risk of priapism, particularly sickle cell anemia, multiple myeloma, and leukemia. For patients with these diseases, the drug may be prescribed only after a careful assessment of the benefit-to-risk ratio. Severe renal impairment requires a dose reduction or complete discontinuation of the drug depending on the clinical situation. Severe hepatic impairment is a contraindication, as tadalafil is metabolized primarily in the liver, and impaired liver function can lead to unpredictable accumulation of the drug. Patients with hereditary galactose intolerance, lactase deficiency, or glucose-galactose malabsorption should take into account the lactose content in TADAFLO 10 tablets.

TADAFLO 10 is not intended for use by women, as clinical data regarding the safety and efficacy of tadalafil in the female population are lacking. The drug is contraindicated in children and adolescents under 18 years of age due to the lack of studies in this age group. In elderly patients, TADAFLO 10 can be prescribed without dose adjustment; however, the higher risk of concomitant diseases and drug interactions in this population should be taken into account. Patients with arterial hypotension or uncontrolled hypertension require special caution when using the drug due to its vasodilatory effect. Before starting therapy with TADAFLO 10, every patient must undergo a complete medical examination and receive individual consultation from a doctor regarding the appropriateness and safety of using the drug.

Interaction of TADAFLO 10 with other drugs and alcohol

The most dangerous drug interaction of TADAFLO 10 is its combination with nitrates and nitric oxide donors, which leads to a sharp decrease in blood pressure and can be life-threatening. CYP3A4 inhibitors, such as ketoconazole, itraconazole, ritonavir, clarithromycin, and grapefruit juice, slow down the metabolism of tadalafil, increasing its concentration in the blood and the risk of side effects; therefore, when co-administered, the dose of TADAFLO 10 should be reduced. Alpha-blockers used to treat BPH and hypertension may enhance the hypotensive effect of tadalafil, so the combination of these drugs requires caution and blood pressure monitoring. Other PDE-5 inhibitors, such as sildenafil or vardenafil, must not be combined with TADAFLO 10 due to the risk of a cumulative effect and the development of severe adverse reactions. The patient must inform the doctor about all medications taken, including over-the-counter drugs and dietary supplements.

Moderate alcohol consumption while taking TADAFLO 10 usually does not lead to a clinically significant decrease in blood pressure; however, excessive amounts of alcohol can enhance the hypotensive effect of tadalafil and increase the risk of dizziness, headache, and orthostatic hypotension. Alcohol can also negatively affect erectile function, reducing the effectiveness of the drug and making it difficult to achieve an erection even during therapy. Patients are advised to limit alcohol consumption to minimal doses or completely abstain from it on the days of taking TADAFLO 10. The effect of the drug on the ability to drive vehicles and operate machinery is usually minimal; however, if dizziness or visual disturbances occur, one should refrain from such activities until symptoms disappear completely. Patients who experience pronounced side effects after taking the drug should be especially careful when driving a car.

Where to buy TADAFLO 10 in Ukraine

TADAFLO 10 is available in pharmacy chains in Ukraine by prescription, as it belongs to the prescription drug group. Purchasing the drug is possible both in physical pharmacies and through licensed online medication booking services, allowing the patient to conveniently order TADAFLO 10 with delivery or pickup from the nearest pharmacy. Before purchasing, it is important to check the pharmacy's license and verify that the product corresponds to original Cipla products, as counterfeits may occur on the market. The cost of TADAFLO 10 may vary depending on the pharmacy chain, region, and the number of tablets in the package, so patients are recommended to compare prices across different sources. The drug should be stored in a dry place protected from light at a temperature not exceeding 25 degrees Celsius, out of the reach of children, for the entire shelf life indicated on the package.

Before purchasing and using TADAFLO 10, it is mandatory to consult a physician who will conduct an examination, confirm the appropriateness of therapy, and provide a prescription. Self-medication of erectile dysfunction can mask serious underlying conditions; therefore, professional medical consultation is an essential prerequisite for the safe use of the drug. An individual's response to TADAFLO 10 may vary, so the first dose of the drug should be taken in comfortable conditions with the ability to monitor one's well-being. Patients are advised to keep the product packaging with the instructions throughout the treatment period for quick access to information regarding dosage and potential side effects. In case of any questions regarding the use of TADAFLO 10, you should contact a doctor or pharmacist who can provide qualified advice.